Ishwaria Subbiah: Privileged to present at the July 1 Rounds of the FDA Oncology Center of Excellence
shared a post on LinkedIn:
“That’s a wrap! July 2024 took me to three countries and four US states for impactful cross-stakeholder dialogue that started on day 1 at Yosemite National Park Service.
Privileged to present at the July 1 Rounds of the FDA Oncology Center of Excellence (OCE) on expanding clinical trial access for all with cancer through thoughtful and definitive actions, envisioned and deployed at scale.
The clarity from Yosemite’s air only added fuel to a superb discussion, with a special thanks, of course, to the internet gods (and the Ahwahnee front desk team) for the solid connection. Looking forward to August!”
Ishwaria Subbiah is the Executive Director for Cancer Care Equity and Professional Wellness at Sarah Cannon Research Institute (SCRI). She is also the medical director of supportive care oncology, health equity and professional well being at The US Oncology Network. Dr. Subbiah focuses on reducing cancer outcomes disparities and diversifying clinical trial participation within SCRI’s combined research network of over more than 1,300 physicians at over 250 locations in 24 states across the US.
Dr. Subbiah is a globally recognized expert in geriatric oncology, symptom management, palliative care, and healthcare professional well-being. She previously was an associate professor in the Division of Cancer Medicine at the University of Texas MD Anderson Cancer Center. She is the Chair for the ASCO Women in Oncology working group and the ASCO State of Cancer Care in America initiative.
